SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Buch, Maya [2 ]
Combe, Bernard [3 ]
Bessette, Louis [4 ]
Song, In-Ho [5 ]
Song, Yanna [5 ]
Suboticki, Jessica [5 ]
Nash, Peter [6 ]
机构：
[1] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[2] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Manchester, Lancs, England
[3] Univ Montpellier, Montpellier, France
[4] Laval Univ, Quebec City, PQ, Canada
[5] AbbVie Inc, Chicago, IL USA
[6] Griffith Univ, Brisbane, Qld, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P106
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [31] Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 weeks from the SELECT-BEYOND Study
    Andrea, Rubbert-Roth
    Genovese, M. C.
    Combe, B.
    Hall, S.
    Sheng, Zhong
    Sebastian, Meerwein
    Roy, Fleischmann
    SWISS MEDICAL WEEKLY, 2019, : 7S - 7S
  • [32] UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-BEYOND STUDY
    Genovese, Mark C.
    Combe, Bernard
    Hall, Stephen
    Rubbert-Roth, Andrea
    Zhong, Sheng
    Meerwein, Sebastian
    Pangan, Aileen
    Fleischmann, Roy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 360 - 361
  • [33] Consistency in Time to Response with Upadacitinib as Monotherapy or Combination Therapy and Across Patient Populations with Rheumatoid Arthritis
    Rubbert-Roth, Andrea
    Combe, Bernard
    Szekanecz, Zoltan
    Hall, Stephen
    Haraoui, Boulos
    Attar, Suzan Mansour Hussein
    Ekwall, Anna-Karin
    Song, Yanna
    Shaw, Tim
    Nagy, Orsolya
    Xavier, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1717 - 1719
  • [34] CONSISTENCY IN TIME TO RESPONSE WITH UPADACITINIB AS MONOTHERAPY OR COMBINATION THERAPY AND ACROSS PATIENT POPULATIONS WITH RHEUMATOID ARTHRITIS
    Rubbert-Roth, A.
    Combe, B.
    Szekanecz, Z.
    Hall, S.
    Haraoui, B.
    Attar, S.
    Ekwall, A. K. H.
    Song, Y.
    Shaw, T.
    Nagy, O.
    Xavier, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 613 - 614
  • [35] Consistency in Time to Response with Upadacitinib as Monotherapy or Combination Therapy and across Patient Populations with Rheumatoid Arthritis
    Rubbert-Roth, Andrea
    Combe, Bernard
    Szekanecz, Zoltan
    Hall, Stephen
    Haraoui, Boulos
    Attar, Suzan Mansour Hussein
    Ekwall, Anna-Karin
    Song, Yanna
    Shaw, Tim
    Nagy, Orsolya
    Xavier, Ricardo
    SWISS MEDICAL WEEKLY, 2022, 152 : 13S - 14S
  • [36] Consistency in Time to Response With Upadacitinib as Monotherapy or Combination Therapy and Across Patient Populations With Rheumatoid Arthritis
    Rubbert-Roth, Andrea
    Combe, Bernard
    Szekanecz, Zoltan
    Hall, Stephen
    Haraoui, Boulos
    Attar, Suzan
    Ekwall, Anna-Karin
    Song, Yanna
    Shaw, Tim
    Nagy, Orsolya
    Xavier, Ricardo
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 832 - 833
  • [37] EFFICACY AND SAFETY OF UPADACITINIB IN A CHINESE SUBGROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Zeng, X.
    Liu, Y.
    Hu, J.
    Li, J.
    Wang, Y.
    Zhao, D.
    Wu, L.
    Xiao, Z.
    Li, Z.
    Xu, J.
    Meerwein, S.
    Xie, Y.
    Liang, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1324 - 1324
  • [38] FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) BY RACE & GEOGRAPHIC REGION
    Gottenberg, Jacques-Eric
    Genovese, Mark C.
    Kalunian, Kenneth
    Mozaffarian, Neelufar
    Bartok, Beatrix
    Matzkies, Franziska
    Gao, Jie
    Guo, Ying
    Walker, David
    Takeuchi, Tsutomu
    de Vlam, Kurt
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 361 - 361
  • [39] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMIZED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
    Smolen, J. S.
    Cohen, S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Zhang, Y.
    Friedman, A.
    Othman, A. A.
    Camp, H. S.
    Pangan, A. L.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S52 - S52
  • [40] Upadacitinib As Monotherapy: A Phase 3 Randomized Controlled Double-Blind Study in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Smolen, Josef S.
    Cohen, Stanley
    Emery, Paul
    Rigby, William F. C.
    Tanaka, Yoshiya
    Zhang, Ying
    Friedman, Alan
    Othman, Ahmed A.
    Camp, Heidi S.
    Pangan, Aileen L.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345